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Abstract: The two classical forms of human trypanoso-
moses are sleeping sickness due to Trypanosoma brucei
gambiense or T. brucei rhodesiense, and Chagas disease
due to T. cruzi. However, a number of atypical human
infections caused by other T. species (or sub-species) have
been reported, namely due to T. brucei brucei, T. vivax, T.
congolense, T. evansi, T. lewisi, and T. lewisi-like. These
cases are reviewed here. Some infections were transient in
nature, while others required treatments that were
successful in most cases, although two cases were fatal.
A recent case of infection due to T. evansi was related to a
lack of apolipoprotein L-I, but T. lewisi infections were not
related to immunosuppression or specific human genetic
profiles. Out of 19 patients, eight were confirmed
between 1974 and 2010, thanks to improved molecular
techniques. However, the number of cases of atypical
human trypanosomoses might be underestimated. Thus,
improvement, evaluation of new diagnostic tests, and
field investigations are required for detection and
confirmation of these atypical cases.
Introduction
Trypanosomes are protozoan parasites found worldwide,
infecting humans, domestic and wild animals, most often
transmitted by blood-sucking insects. The typical pathogenic
human trypanosomoses are sleeping sickness, or human African
trypanosomosis (HAT) [1], and the Latin American Chagas
disease [2]. HAT is a fatal disease occurring in sub-Saharan Africa
and transmitted by tsetse flies, caused by two subspecies of
trypanosomes: T. brucei gambiense (the chronic form) or T. b.
rhodesiense (the acute form) [1], which is derived from the animal
parasite T. b. brucei that has acquired the ability to infect humans
[1]. Chagas disease, caused by T. cruzi, is transmitted by triatomine
bugs but also orally [3], congenitally, and via blood transfusion or
organ transplantation [2]. The disease is endemic in Latin
America and in most cases is chronic and asymptomatic [2]. In
addition to these species, T. rangeli is also a human infective species,
although considered nonpathogenic [1].
In contrast to these species or sub-species, most trypanosomes
were thought to be infective only to animals, such as T. b. brucei, T.
congolense, and T. vivax, the agents of the complex animal
trypanosomosis called ‘‘nagana’’ in Africa. T. evansi is responsible
for a widely distributed disease called ‘‘surra’’ in domestic and wild
animals found in Asia, Africa, South America, and even Europe
[4]. T. lewisi is a worldwide non-pathogenic parasite of rats
transmitted by fleas [1].
Humans possess an innate protection against most Trypanosoma
species [5]. However, 19 cases of atypical human trypanosomoses
(a-HT) caused by T. b. brucei [1,6–8], T. vivax [1], T. congolense [9],
T. evansi [10–13] and T. lewisi [14–21], which were all considered
non-infective to humans, have been reported. In recent years, T.
evansi and T. lewisi have emerged as potentially pathogenic for
humans. While some of these cases reviewed herein were transient,
six required trypanocidal treatments that were mostly successful,
although two patients died [11,21]. Out of 15 humans cases
recorded between 1974 and 2010, nine have been reported since
2003. Some cases were identified by microscopic observation of
trypanosomes only and others using molecular tools, as described
hereafter.
With the improvement of diagnostic techniques, in particular
molecular assays, it is now easier to identify Trypanosoma species
and, hence, investigate a-HT. Furthermore, the lack of awareness
and sometimes difficult access to health care services reinforce the
hypothesis that the number of cases of a-HT might be
underestimated. Therefore, it was decided to review these cases
of a-HT, leading to an international collaboration to further
evaluate their actual occurrence.
Methods
References for this article were identified through PubMed
searches for articles published from 1978 to 2011 using the terms
‘‘Trypanosoma’’, ‘‘human’’, ‘‘atypical’’, ‘‘lewisi’’, ‘‘evansi’’, ‘‘congo-
lense’’, and ‘‘Herpetosoma’’. Relevant books and articles published
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between 1933 and 2011 were selected through searches in the
authors’ personal files.
Accession Numbers
Accession numbers on Genbank, for the ITS1 (ribosomal DNA)
of T. lewisi mentioned in the manuscript are: HQ437158 (T. lewisi
specific primers), GU252222.1 (human infant case in Thailand),
GU252216.1–GU252221.1, DQ345394.1, FJ011094.1, EU86119
2.1, EU599639.1, FJ011095.1. Human serum associated protein
(SRA) CAD90580.1, GI34368410. ApoL1 gene ID 8542, ApoL1
protein AAI4340.1. RoTat 1.2 variable surface glycoprotein
(VSG) CAI34904.
Identification of Atypical Human Cases of
Trypanosomoses by Microscopic Observation
The 19 atypical human cases of trypanosomoses detected by
microscopy reported so far are presented in Table 1, and
morphology of T. evansi and T. lewisi is shown in Figure 1 and
Figure 2, respectively (as observed in infected rodents). Among
them, 11 cases were identified by morphological analysis of
trypanosomes only. Unfortunately, most of these cases were poorly
described, such as a case of human infection by T. vivax (Table 1,
patient number 1) from Ghana in 1917 [1]. In 1930, Mesnil
reported an accidental T. b. brucei infection of a technician (patient
number 2) using a syringe containing infected blood [1]. In 1947,
out of seven volunteers infected with T. b. brucei by bites of infected
tsetse flies, one (patient number 3) acquired a transient infection
for 3 weeks [6]. In 1988, the blood incubation infectivity test [22]
of an autochthonous sleeping sickness case in Western Ethiopia
indicated that the patient was infected with T. b. brucei (patient
number 4). This patient was cured but no information was given
on clinical signs and treatment [7].
T. lewisi was found in the blood of three patients suffering from
short febrile episodes in Malaysia (patient number 12 in 1933) and
India (patients number 13 and 14 in 1974) [14,15]. Infection was
only transient and patients recovered without treatment. In 2006,
trypanosomes were detected in blood of a 7-week-old baby (patient
number 17) living in Mumbai (India). She was suffering from fever
and presented hepatosplenomegaly. Morphological examination
of trypanosomes indicated T. lewisi or T. lewisi-like. The patient
self-cured in 15 days [16,17].
In 1977, an accidental infection by a syringe containing T.
evansi-infected blood was reported in India. The patient (patient
number 7) was treated with Atoxyl (an arsenic derivative used in
HAT treatment before the currently used melarsoprol drug) [10].
In 1999, a human suspected of being infected with T. evansi was
reported in Sri Lanka (patient number 8). He suffered from
headache and episodes of hyperthermia concomitant to high levels
of parasitaemia. Again, the case was not thoroughly documented
[11]. In 2005, another case of T. evansi was reported in West
Bengal State, India. The patient died 2 days after admission to a
Kolkata hospital (patient number 10), but it is only suspected that
death was caused by the related trypanosome infection [11]. In
2010, in Egypt, a cattle farmer was infected with T. evansi and
cured; however, this case (patient number 11) remains doubtful
because no attempts were made to ascertain the parasite species
using molecular techniques and no clinical details or the drug used
for treatment were given [12]. Reliable criteria such as the size and
the position of the kinetoplast, the location of the nucleus, the
development of the undulating membrane, the shape of the
posterior end of the parasite, the existence of free flagellum, etc.
(Figure 3), may allow sub-genus identification based on the
morphological features of the parasites. However, the species
identification is not possible, and, the parasitemia is sometime too
low for such observations to be conclusive. Consequently,
molecular identification of trypanosomes is most often necessary.
Molecular Assays to Confirm Atypical Human Cases of
Trypanosomoses
In 1998 a mixed infection with T. brucei spp. and T. congolense
was detected in the blood of a patient (patient number 6) in Coˆte
d’Ivoire. The latter trypanosome species was confirmed by PCR
assays whereas T. brucei was only identified at the species level;
therefore T. b. gambiense cannot be ruled out. The patient was
successfully treated using pentamidine [9]. In 2003 in Ghana, a
patient suspected of having HAT (patient number 5) who
recovered without treatment was later confirmed to be infected
with T. b. brucei by molecular analysis of archived blood slides [8].
The number of potentially similar cases on the African continent
remains difficult to evaluate. Conventional diagnosis of HAT is
based on microscopic detection of trypanosomes in blood,
lymphatic fluid, and/or cerebrospinal fluid (CSF). This technique
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Key Learning Points
N The classical human trypanosomoses are human African
trypanosomosis (HAT) or sleeping sickness, and Chagas
disease, the Latin American human trypanosomosis.
N Atypical human infections caused by Trypanosoma
species that normally are restricted to animals have
been reported. These cases of atypical human trypano-
somoses (a-HT) are mostly transient, but some require
treatment and can be fatal.
N Only a few cases of a-HT have been fully confirmed,
especially in Asia, leading to the hypothesis that the
actual prevalence is probably underestimated.
N The detection of a case of a-HT should be based on
observation of the parasite by direct microscopy.
Evaluating/improving the diagnoses through serological
and PCR assays would help in detecting and identifying
atypical trypanosomosis infections in humans. These
laboratory research and field activities are needed to
evaluate the actual occurrence of atypical cases.
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used in medical surveys does not allow discrimination between T.
b. brucei, T. b. gambiense, and T. b. rhodesiense, since they are
morphologically indistinguishable [1].
In 2004, the first molecularly confirmed case of a-HT caused by
T. evansi was described in Seoni, India, in a farmer (patient number
9) showing a fluctuating trypanosome parasitaemia associated with
febrile episodes over the course of 5 months [13]. The same signs
were observed in a Sri Lankan patient in 1999 (patient number 8).
Microscopical examination of blood smears showed high numbers
of parasites confirmed as T. evansi by molecular techniques [23].
Figure 1. T. evansi on a Giemsa-stained blood smear from an experimentally infected rat (credit, Marc Desquesnes). Size of the
parasite (15–34 mm), small (diameter 0.6–0.7 mm) and subterminal kinetoplast, sharp posterior end, central nucleus, large undulating membrane, and
free flagellum are the most striking features of the slender forms of the sub-genus Trypanozoon.
doi:10.1371/journal.pntd.0002256.g001
Figure 2. T. lewisi (adult form) on a Giemsa-stained blood smear from an experimentally infected rat (credit, Marc Desquesnes). Size
of the parasite (21–36 mm), kinetoplast rode shaped, large (160.7 mm) and subterminal, very sharp posterior end, posterior nucleus, large undulating
membrane, ‘‘C shape’’ of the parasite, and free flagellum are the most striking features of the adult forms of the sub-genus Herpetosoma, to which
belong T. lewisi-like parasites.
doi:10.1371/journal.pntd.0002256.g002
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Additional examinations did not show central nervous system
invasion by the parasites and the patient was successfully treated
with suramin [24].
In 2003, trypanosomes were detected in blood and CSF of a
Gambian baby presenting a severe clinical status with general
oedema although no neurological abnormalities were found
(patient number 15). PCR assays with primers flanking trypano-
some ribosomal DNA internal transcribed spacer 1 (ITS1) resulted
in amplicon of,623 bp that corresponded to the expected size for
T. lewisi and allied species (T. lewisi-like) [19], which are closely
related species of the subgenus Herpetosoma; the amplified ITS
sequence differed by just one nucleotide from T. lewisi [25]. The
patient was successfully treated with melarsoprol [18]. Two other
babies were reportedly infected with T. lewisi or T. lewisi-like. In
2003 in Thailand, trypanosomes were observed in blood from a
45-day-old infant (patient number 16) displaying fever, anaemia,
cough, and anorexia. PCR (ITS1) confirmed the T. lewisi-like
infection. The patient was treated with gentamicin [19]. In Bagpat
India, 2010, a 37-day-old infant (patient number 19) with fever,
anorexia, and lethargy showed T. lewisi on blood smears. Analysis
of the DNA sequence (ITS1) amplified by PCR with this infant’s
blood confirmed the species identification. The patient was treated
using pentamidine for 10 days, and on the seventh day peripheral
blood smear did not show any parasites [20]. In 2007, in Pune,
India, an adult (patient number 18) was infected by T. lewisi
detected by microscopy of blood smears and confirmed by PCR
assay (not detailed in the publication). However, treatment with
suramin had to be interrupted because of renal complications
leading to the patient’s death [21]. This indicates prudence is
required when managing a-HT. Toxicity of the drugs and
parasite-related pathogenicity must be assessed.
Immunity of Humans to African Animal Trypanosomes
The natural immunity of humans to the livestock pathogen T. b.
brucei, but not to the morphologically indistinguishable human
pathogens T. b. gambiense and T. b. rhodesiense, is due to the selective
killing of the parasite by normal human serum (NHS). While the
mechanism is still not known in the case of T. b. gambiense, a
truncated protein named serum resistance-associated (SRA)
appears to be the dominant factor responsible for resistance of
T. b. rhodesiense to NHS [26]. Human innate immunity against
African animal trypanosomes stems from the trypanolytic activity
of the human-specific serum protein called apolipoprotein L-I
(apoL-I), which is partially associated with high-density-lipoprotein
(HDL) [5,27–29].
However, under certain circumstances, it would appear that T.
congolense, T. vivax, and T. evansi can be resistant to human plasma
[30–33]. The serum of an Indian patient (Table 1, number 9)
infected with T. evansi presented a lack of trypanolytic activity due
to frameshift mutations in both apoL-I alleles. Therefore, the lack
of efficient apoL-I can explain this human T. evansi infection [34].
More isolates of T. evansi from various regions should be tested to
check their sensitivity to NHS, and prevalence of apoL-I mutations
should be investigated. Similarly, the trypanolytic activity of NHS
from various geographical origins could be evaluated against a
reference strain of T. evansi and the prevalence of the apoL-I deficit
should be investigated in several human populations, to evaluate
the potential risk of T. evansi infection in humans.
Table 1. The 19 cases of atypical human trypanosomoses.
Patient
Number Location
Trypanosome Species/Sub-
species Date
Parasite
Identification
Methoda Fever Treatment Outcome
Reference
Number
1 Ghana T. vivax 1917 Morphology ND ND ND [1]
2 Pasteur Institute T. b. brucei 1930b Morphology ND ND ND [1]
3 Congo T. b. brucei 1947c Morphology Present None Self-cure [6]
4 Ethiopia T. b. brucei 1987 Morphology BIIT ND ND Cure [7]
5 Ghana T. b. brucei 2003 PCR Present None Self-cure [8]
6 Coˆte d’Ivoire T. congolense 1998 PCR Present Pentamidine Cure [9]
7 India T. evansi 1977b Morphology Present Atoxyl Cure [10]
8 Sri Lanka T. evansi 1999 Morphology Present None Self-Cure [11]
9 India, Seoni T. evansi 2004 PCR Present Suramin Cure [13]
10 India, Kolkata T. evansi 2005 Morphology Present None Death [11]
11 Egypt T. evansi 2010 Morphology Present ND Cure [12]
12 Malaysia T. lewisi 1933 Morphology Present None Self-cure [14]
13 India, Parsda T. lewisi 1974 Morphology Present None Self-cure [15]
14 India, Parsda T. lewisi 1974 Morphology Present None Self-cure [15]
15 The Gambia T. lewisi-like 2003 PCR/S Present Melarsoprol Cure [18]
16 Thailand T. lewisi-like 2003 PCR/S Present Antibiotic Cure [19]
17 India, Mumbai T. lewisi 2006 Morphology Present None Self-cure [16,17]
18 India, Pune T. lewisi 2007 PCR Present Suramine Death [21]
19 India, Bagpat T. lewisi 2010 PCR/S Present Pentamidine Cure [20]
aMicroscopy of blood smear and morphology of trypanosomes.
bAccidental inoculation with a syringe.
cVolunteer exposed to tsetse bites.
BIIT, blood incubation infectivity test; ND, no data; PCR, PCR molecular assays; PCR/S, PCR molecular assays followed by sequencing of amplicons.
doi:10.1371/journal.pntd.0002256.t001
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Immunity to T. lewisi and T. lewisi-Like Parasites
In contrast to T. b. brucei, little is known about the innate
immune response that prevents the establishment of human
infection by other trypanosome species. T. lewisi and T. lewisi-like
species are in general highly host-restricted to rodents and
lagomorphs. T. lewisi is primarily a parasite of Rattus spp. but
little is known about the mechanisms involved in the highly host-
species restriction of T. lewisi and related species and, consequent-
ly, why other animal species including primates are not naturally
infected under normal conditions.
During the course of infection in the rat, T. lewisi produces two
antigenic variants: the first represents the initial reproducing
population and the second, the non-reproducing population. The
reproductive forms are inhibited by ablastin [35] and the late
population by antibody dependent cytotoxicity. The capacity to
evade trypanocidal and ablastic antibodies and complement is
crucial in the establishment of the infection. In rats infected with
T. lewisi the parasitaemia normally resolves within 30 days.
Thereafter, the rodents become immune to re-infection and
complement does not appear to play a major role in this process
[36,37]. However, the inability of T. lewisi to infect a range of
mammalian species appears to be due to the activation of
complement through the alternative pathway, agglutinins, and
opsonins [36]. T. lewisi infection of non-natural hosts, including
non-human and human primates, apparently, lasts a very short
time compared to infections in natural hosts [36,38]. Infection
with T. lewisi was also transient in some patients from Malaysia
and India who recovered without treatment [14–17]. It seems that
only immature or depressed immune systems could render this
species an opportunistic parasite of primates [37]. However,
human resistance mechanisms against infection by this species
have not been investigated yet.
Investigations in Rodents
Following the detection of T. lewisi in a sick Thai infant (Table 1,
patient number 16), T. lewisi infection in rodents was investigated
to identify possible sources of human cases in Thailand. Blood
samples from 276 rodents were tested with PCR (ITS1), and the
trypanosome species identified by ITS1 sequence analysis. T. lewisi
was detected in Rattus spp. (14.3%) and Bandicota spp. (18.0%). The
ITS1 sequence from one sample from R. tanezumi showed 96.4%
similarity compared to the sequence amplified from the blood of
the T. lewisi-infected Thai infant [19,38]. Habitats where rodents
were collected suggested that the degree of anthropization may
influence the transmission of T. lewisi [39]. The hypothesis that T.
lewisi can be transmitted from rats to non-human primates by
rodent fleas arose from the finding of T. lewisi infection in captive
monkeys infected by fleas, and living in poor conditions in rat-
infested cages [37]. This hypothesis is corroborated by the fact that
humans infected with T. lewisi also lived in poor dwellings certainly
infested by domestic rats [19].
Improving Diagnostic Methods for a-HT
Several techniques such as IFAT, ELISA [40,41], and PCR-
based methods [42] have been developed for the detection of
trypanosomes in animals, especially for T. evansi. Serological
techniques making use of crude antigens proved to have strong
inter-specific cross-reactions [43]. They are therefore not consid-
Figure 3. T. lewisi and T. evansi on a Giemsa-stained blood smear from a rat submitted to a mixed experimental infection (credit,
Marc Desquesnes). Smeared and stained in the same conditions, the parasites exhibit here their striking characteristics: the size of the kinetoplast
(large in T. lewisi and small in T. evansi) is the most reliable criteria to distinguish these sub-genera; however, other characteristics can be observed,
such as: the size of the parasite (T. lewisi.T. evansi), the nucleus position (central for T evansi, posterior for T. lewisi), the undulating membrane
development (exhibiting regular waves in T. evansi and irregular ones in T. lewisi). Finally, an unusual feature can be observed on one specimen of T.
lewisi with a very long posterior extremity, this morphotype use to be called ‘‘longicaudale’’ [1].
doi:10.1371/journal.pntd.0002256.g003
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ered as species-specific, although their genus specificity is
satisfactory [43] and some improvements are expected for more
specific antigens such as VSG Rotat 1.2 T. evansi [44]. Few of these
techniques have been applied to a-HT.
In 2005, a serological survey was conducted using the Card
Agglutination Test for Trypanosomosis/Trypanosoma evansi
(CATT/T. evansi) [45] in the residential area of the patient
number 9 (Indian case of T. evansi infection in Seoni [13]). Out of
1,806 individuals tested with CATT/T. evansi, 81 were positive
using serum [46]. No trypanosome was detected in the blood of 60
persons positive to the test at a significant serum dilution
(minimum 1:4). These results may suggest a frequent human
exposure to T. evansi in the study area and possibly a frequent
transmission of parasites to humans leading to transient infections
in a ‘‘normal’’ immune population. The specificity of the CATT/
T. evansi test has not been previously evaluated for human
screening and was used for the first time in this study in Asia.
Consequently, this and other diagnostic techniques must be
evaluated for screening a-HT in human populations, such as
ELISA-T. evansi, and the immune trypanolysis test with
T. evansi RoTat 1.2, which is considered to be highly specific for
T. evansi infection in livestock but cannot detect some strains of T.
evansi when the RoTat 1.2 VSG gene is missing [47]. So far,
species-specific identification of Trypanosoma species can only be
implemented by PCR with various sets of primers [48], or by
sequence analyses of PCR products [37].
More recently, molecular tools were developed for the species-
specific identification of T. lewisi by PCR or LAMP techniques
[38,49]. These methods are under evaluation in several
rodent species and might be useful in humans. Species-specific
diagnoses will allow a better assessment of the prevalence of a-
HT and a more accurate characterization of cases. They could
also be useful to assess the results of potential treatments, with the
goal of improving the management of any emerging a-HT
infection.
Conclusion
The number of a-HT cases attributable to primarily
animal trypanosomes is possibly underestimated. An international
collaboration could help develop tools and strategies to better
detect infection, identify the causative species, and manage new
cases. The risk and potential impact related to a-HT cannot
be evaluated thoroughly at the present time because diagnostic,
clinical, and epidemiological data remain insufficient. Further
studies are required to address relevant aspects of a-HT: (i)
enhance awareness and detection in suspected areas where a-
HT could be prevalent; (ii) real-time and detailed reports of a-HT
including the clinical history of the patients; (iii) easy, sensitive,
and species-specific methods for identification of the trypanosome;
(iv) investigations on potential vectors, reservoirs (wild and
domestic animals), and infection pathway. Therefore, it is
perfectly justified to establish an international network to evaluate
whether a-HT could be an emerging and neglected threat to
human health.
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